Navigation Links
Study Finds Millions More May Benefit From Statins
Date:3/19/2009

New prescribing criteria could prevent thousands of heart attacks

THURSDAY, March 19 (HealthDay News) -- Cholesterol-lowering statins could cut the risk of heart attacks in as many as 6.5 million Americans who have low cholesterol but high levels of a blood marker for inflammation, researchers report.

Statins are known to prevent subsequent heart attacks and strokes in patients who've already suffered one of these cardiovascular events, and the drugs also protect people who haven't had a heart attack or stroke but are at increased risk for developing cardiovascular disease due to factors such as high cholesterol or diabetes.

Based on these guidelines, about 33 million older adults are eligible to take statins, according to background information in a news release about the study.

However, about half of all cardiovascular events occur in people who don't have high cholesterol, and about 20 percent of such events occur in people with no identifiable cardiovascular disease risk factors, noted Dr. Erin D. Michos, an assistant professor of medicine at Johns Hopkins University School of Medicine and its Heart and Vascular Institute.

A study published last year found statins protect against heart attack and strokes in older adults with low cholesterol but with high levels of C-reactive protein (CRP), a blood marker for inflammation.

To determine how many Americans with low cholesterol (below 130 mg/dl) and high CRP levels would benefit from taking statins, Michos and Hopkins cardiology professor Dr. Roger S. Blumenthal analyzed 1999 to 2004 data from the National Health and Nutrition Examination Survey (NHANES).

They concluded that 6.5 million older adults with low cholesterol and high CRP might benefit from taking statins. That number would increase to 10 million people if the cholesterol level cutoff was 160 mg/dl, the point at which many doctors decide to prescribe statins.

"We're showing that doctors may be able to prevent thousands of heart attacks, strokes and deaths each year if we expand statin-prescribing criteria to include C-reactive protein levels, something we can assess as part of a simple blood test," Michos said in the Hopkins news release.

Using these new criteria to prescribe statins to older adults could prevent about 260,000 cardiovascular events over five years, the researchers said.

The study was published in the March 17 issue of the Journal of the American College of Cardiology.

More information

The American Academy of Family Physicians has more about cholesterol-lowering drugs.



-- Robert Preidt



SOURCE: Johns Hopkins Medicine, news release, March 18, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Gleevec Prevents Return of Intestinal Cancer, Study Confirms
2. New Clinical Study News for Treatment of Sinusitis - Sinus Infection and Allergy Suffers Now Have a New Effective Form of Relief through Sinus Dynamics
3. Study finds extensive patient sharing among hospitals; could impact spread of infectious diseases
4. Northern California Cancer Center Study Seeks to Improve Colon Cancer Screening in Vietnamese Communities
5. Study finds how brain remembers single events
6. MHA to Release Results of Second Annual Independent Long Term Care Member Study
7. Spinal taps carry higher risks for infants and elderly, study shows
8. Study finds biological clue in brain tumor development
9. Researcher wins $2.6 million grant for depression care study
10. Study gives more proof that intelligence is largely inherited
11. MRSA study suggests strategy shift needed to develop effective therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Finds Millions More May Benefit From Statins
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... While it’s ... poses a problem. Fortunately, an inventor from Austin, Texas, has identified a solution. , ... medication in darkness or restricted lighting. As such, it eliminates the need to turn ...
(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... Shelton, CT (PRWEB) , ... October 13, 2017 , ... ... and long-term care services, staged a mock evacuation of the facility as part of ... Department, Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
(Date:9/12/2017)... PARIS and NEW YORK , Sept. 12, ... ethical performance ratings for global supply chains, has published the first annual ... the CSR performance of more than 20,400 companies evaluated by EcoVadis, based ... years 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
Breaking Medicine Technology: